1. Home
  2. SPRY vs PLUS Comparison

SPRY vs PLUS Comparison

Compare SPRY & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • PLUS
  • Stock Information
  • Founded
  • SPRY 2015
  • PLUS 1990
  • Country
  • SPRY United States
  • PLUS United States
  • Employees
  • SPRY N/A
  • PLUS N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • PLUS Retail: Computer Software & Peripheral Equipment
  • Sector
  • SPRY Health Care
  • PLUS Technology
  • Exchange
  • SPRY Nasdaq
  • PLUS Nasdaq
  • Market Cap
  • SPRY 1.8B
  • PLUS 1.9B
  • IPO Year
  • SPRY N/A
  • PLUS 1996
  • Fundamental
  • Price
  • SPRY $17.50
  • PLUS $69.26
  • Analyst Decision
  • SPRY Strong Buy
  • PLUS
  • Analyst Count
  • SPRY 4
  • PLUS 0
  • Target Price
  • SPRY $28.75
  • PLUS N/A
  • AVG Volume (30 Days)
  • SPRY 1.1M
  • PLUS 155.0K
  • Earning Date
  • SPRY 08-13-2025
  • PLUS 08-07-2025
  • Dividend Yield
  • SPRY N/A
  • PLUS N/A
  • EPS Growth
  • SPRY N/A
  • PLUS 9.30
  • EPS
  • SPRY N/A
  • PLUS 4.46
  • Revenue
  • SPRY $97,122,000.00
  • PLUS $2,170,452,000.00
  • Revenue This Year
  • SPRY N/A
  • PLUS $3.30
  • Revenue Next Year
  • SPRY $170.64
  • PLUS $2.29
  • P/E Ratio
  • SPRY N/A
  • PLUS $16.07
  • Revenue Growth
  • SPRY 971120.00
  • PLUS N/A
  • 52 Week Low
  • SPRY $9.52
  • PLUS $53.83
  • 52 Week High
  • SPRY $18.90
  • PLUS $106.98
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 50.83
  • PLUS 55.95
  • Support Level
  • SPRY $17.34
  • PLUS $62.42
  • Resistance Level
  • SPRY $18.63
  • PLUS $65.39
  • Average True Range (ATR)
  • SPRY 0.63
  • PLUS 2.04
  • MACD
  • SPRY -0.12
  • PLUS 0.05
  • Stochastic Oscillator
  • SPRY 27.56
  • PLUS 70.93

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

Share on Social Networks: